{"id":199174,"name":"ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)","slug":"association-of-accessible-medicines-formerly-known-as-gpha","state":"DC","country":"United States of America","description":"Trade Organization for Generic Drug Manufacturers and Distributers","totalSpending":1830000,"filings":32,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":240000},{"year":2020,"income":220000},{"year":2021,"income":220000},{"year":2022,"income":240000},{"year":2023,"income":200000},{"year":2024,"income":230000},{"year":2025,"income":240000}],"issues":["PHA","TRD"],"firms":["FIERCE GOVERNMENT RELATIONS"],"lobbyists":["ERIC ZULKOSKY","WILLIAM BLALOCK","MICHAEL CHAPPELL","KIRSTEN CHADWICK","ALEIX JARVIS","KATE HULL","WILLIAM PIPER","TYLER STEPHENS","PATRICK CLIFTON","JACOBUS VREEBURG"],"govEntities":["Executive Office of the President (EOP)","HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)","Treasury, Dept of","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues relating to generic drug competition, drug pricing, S. 974 - CREATES Act of 2017, H.R.2212 - CREATES Act of 2017, S. 2514- PACED Act","Issues relating to generic drug competition, drug pricing, S. 974 - CREATES Act of 2017, H.R.2212 - CREATES Act of 2017, S. 2514- PACED Act, Hatch Waxman Integrity Act","Issues relating to generic drug competition, drug pricing, S. 974 - CREATES Act of 2017, H.R.2212 - CREATES Act of 2017, Hatch Waxman Integrity Act","USMCA/NAFTA","USMCA/NAFTA"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}